Skip to main content

Hair and Trichology

Featured

Alopecia
News
03/31/2026
Riya Gandhi, MA
Meta-analysis reveals robust SALT improvements regardless of age, dose, or prior JAK inhibitor exposure.
Meta-analysis reveals robust SALT improvements regardless of age, dose, or prior JAK inhibitor exposure.
Meta-analysis reveals robust...
03/31/2026
The Dermatologist
oral medicine
News
03/31/2026
Riya Gandhi, MA
Combined nutraceutical formulation shows measurable improvements in hair resistance and structural biomarkers over 90 days.
Combined nutraceutical formulation shows measurable improvements in hair resistance and structural biomarkers over 90 days.
Combined nutraceutical...
03/31/2026
The Dermatologist
News
03/30/2026
Riya Gandhi, MA
Retrospective data suggest meaningful hair regrowth and tolerability in children with severe, treatment-resistant alopecia areata.
Retrospective data suggest meaningful hair regrowth and tolerability in children with severe, treatment-resistant alopecia areata.
Retrospective data suggest...
03/30/2026
The Dermatologist
alopecia areata
News
03/30/2026
Riya Gandhi, MA
Phase 3 subgroup analysis shows significant scalp and facial hair regrowth with upadacitinib, with consistent safety across age groups.
Phase 3 subgroup analysis shows significant scalp and facial hair regrowth with upadacitinib, with consistent safety across age groups.
Phase 3 subgroup analysis shows...
03/30/2026
The Dermatologist
alopecia areata
News
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist

Expert Insights

Dr Natasha Atanaskova Mesinkovska
Podcasts
05/16/2023
Natasha Atanaskova Mesinkovska, MD, PhD
In this exclusive interview, Dr Natasha Atanaskova Mesinkovska discussed her session on hair loss and treatment options for alopecia areata.
In this exclusive interview, Dr Natasha Atanaskova Mesinkovska discussed her session on hair loss and treatment options for alopecia areata.
In this exclusive interview, Dr...
05/16/2023
The Dermatologist
CH
Videos
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Feature Story
02/16/2021
Lauren Mateja
With the emphasis on emergent conditions and chronic disease management, dermatology sometimes overlooks the importance of hair. Patients who have seen a dermatologist may exhibit signs and symptoms of alopecia,...
With the emphasis on emergent conditions and chronic disease management, dermatology sometimes overlooks the importance of hair. Patients who have seen a dermatologist may exhibit signs and symptoms of alopecia,...
With...
02/16/2021
The Dermatologist
Feature Story
07/15/2020
Androgenetic alopecia (AGA) is a common form of hair loss that affects an estimated 80 million Americans.1 In men, it can begin as early as the teen years and follows a characteristic pattern, and in women, AGA...
Androgenetic alopecia (AGA) is a common form of hair loss that affects an estimated 80 million Americans.1 In men, it can begin as early as the teen years and follows a characteristic pattern, and in women, AGA...
...
07/15/2020
The Dermatologist
Feature Story
09/04/2008
More than 50% of the population of men in their 50s has cosmetically significant male pattern hair loss. No doubt, the pressure on individuals to look younger comes from all directions in our society.
More than 50% of the population of men in their 50s has cosmetically significant male pattern hair loss. No doubt, the pressure on individuals to look younger comes from all directions in our society.
More than 50% of the population...
09/04/2008
The Dermatologist
MDT Panel Thumbnail
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
In this closing discussion, faculty share practical recommendations for strengthening multidisciplinary care in high-risk CSCC, emphasizing timely communication, collaboration across specialties, and continuity of care in both academic and...
In this closing discussion, faculty share practical recommendations for strengthening multidisciplinary care in high-risk CSCC, emphasizing timely communication, collaboration across specialties, and continuity of care in both academic and...
In this closing discussion,...
11/18/2026
The Dermatologist
Video 3 thumbnail image
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
Through a case involving recurrent scalp CSCC and cognitive impairment, faculty explore how recurrence risk, treatment feasibility, patient preferences, and caregiver involvement influence decisions about surgery, radiation, and adjuvant...
Through a case involving recurrent scalp CSCC and cognitive impairment, faculty explore how recurrence risk, treatment feasibility, patient preferences, and caregiver involvement influence decisions about surgery, radiation, and adjuvant...
Through a case involving...
11/18/2026
The Dermatologist
Video 2 thumbnail image
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
The panel discusses a patient with high-risk CSCC, exploring how disease characteristics, immune status, and multidisciplinary input inform postoperative treatment decisions and consideration of adjuvant immunotherapy.
The panel discusses a patient with high-risk CSCC, exploring how disease characteristics, immune status, and multidisciplinary input inform postoperative treatment decisions and consideration of adjuvant immunotherapy.
The panel discusses a patient...
11/18/2026
The Dermatologist
Video 1 thumbnail image
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
In this case-based discussion, a multidisciplinary panel examines recurrent high-risk CSCC, including the distinction between local recurrence and in-transit disease, considerations for additional surgery and radiation, and the role of...
In this case-based discussion, a multidisciplinary panel examines recurrent high-risk CSCC, including the distinction between local recurrence and in-transit disease, considerations for additional surgery and radiation, and the role of...
In this case-based discussion, a...
11/18/2026
The Dermatologist
Dean berman
Videos
11/17/2026
Dr Dean Berman discusses the proposed HHS policy on compounded peptides, including BPC-157, KPV, and TB-500, and their potential applications in dermatology.
Dr Dean Berman discusses the proposed HHS policy on compounded peptides, including BPC-157, KPV, and TB-500, and their potential applications in dermatology.
Dr Dean Berman discusses the...
11/17/2026
The Dermatologist
Jacob
Videos
11/16/2026
Carolyn Jacob, MD; Riya Gandhi, MA
Dr Carolyn Jacob discusses emerging therapies that are expanding hair restoration beyond traditional treatments like minoxidil and finasteride.
Dr Carolyn Jacob discusses emerging therapies that are expanding hair restoration beyond traditional treatments like minoxidil and finasteride.
Dr Carolyn Jacob discusses...
11/16/2026
The Dermatologist
Dr Aaron Farberg
Videos
11/11/2026
Aaron S. Farberg, MD; Jessica Garlewicz
Aaron Farberg, MD, discusses how emerging genomic tools, including the AdvanceAD-Tx test, may help identify distinct molecular profiles in patients with atopic dermatitis and guide more personalized treatment selection.
Aaron Farberg, MD, discusses how emerging genomic tools, including the AdvanceAD-Tx test, may help identify distinct molecular profiles in patients with atopic dermatitis and guide more personalized treatment selection.
Aaron Farberg, MD, discusses how...
11/11/2026
The Dermatologist
Goldberg
Videos
11/09/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how dermatologists can safely use energy-based devices in patients with skin of color while minimizing risks such as hyperpigmentation, hypopigmentation, and burns.
Dr David Goldberg discusses how dermatologists can safely use energy-based devices in patients with skin of color while minimizing risks such as hyperpigmentation, hypopigmentation, and burns.
Dr David Goldberg discusses how...
11/09/2026
The Dermatologist
Dr Lisa Swanson
Videos
11/03/2026
Elizabeth Swanson, MD; Jessica Garlewicz
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing atopic comorbidity.
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing atopic comorbidity.
Lisa Swanson, MD, emphasizes the...
11/03/2026
The Dermatologist
type 2 KOL roundtable part 1
Videos
11/02/2026
Raj Chovatiya, MD, PhD; Tina Bhutani, MD, MAS; Daniel C. Butler, MD; Jason Ezra Hawkes, MD, MS, FAAD
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases,.
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases,.
Dr Raj Chovatiya moderates an...
11/02/2026
The Dermatologist

News

alopecia areata
News
01/16/2025
Jessica Garlewicz
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the importance of patient preferences in optimizing treatment strategies for severe alopecia areata.
A new analysis highlights the...
01/16/2025
The Dermatologist
alopecia areata
News
12/19/2023
Jessica Garlewicz
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the current literature on the gut-skin connection in alopecia to summarize interventions that impact hair growth through modulation of the gut or skin microbiome.
Researchers aimed to explore the...
12/19/2023
The Dermatologist
alopecia areata
News
12/19/2023
Jessica Garlewicz
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the treatment preferences of both adult (≥18 years) and adolescent (12–17 years) patients with alopecia areata in the United States and Europe.
Researchers aimed to gauge the...
12/19/2023
The Dermatologist
alopecia areata
News
12/12/2023
Jessica Garlewicz
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the diagnostic accuracy of alopecia areata, trichotillomania, nevus sebaceous, and linear scleroderma en coup de sabre, all of which can manifest as linear alopecia,
Researchers aimed to enhance the...
12/12/2023
The Dermatologist
alopecia areata
News
12/12/2023
Jessica Garlewicz
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate the potential causal relationship between rheumatoid arthritis and alopecia areata using the Mendelian randomization design.
Researchers aimed to elucidate...
12/12/2023
The Dermatologist
alopecia areata
News
11/30/2023
Jessica Garlewicz
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results from BRAVE-AA1 and BRAVE-AA2 clinical trials, investigating the impact of baricitinib treatment on scalp hair regrowth over 52 weeks.
Researchers combined results...
11/30/2023
The Dermatologist
alopecia areata
News
11/20/2023
Jessica Garlewicz
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the growing evidence supporting the efficacy of JAK inhibitors in treating alopecia areata.
Researchers aimed to address the...
11/20/2023
The Dermatologist
alopecia areata
News
11/17/2023
Jessica Garlewicz
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the potential benefits of autologous adipose tissue injection, in the treatment of both scarring and nonscarring alopecia.
Researchers aimed to explore the...
11/17/2023
The Dermatologist
alopecia areata
News
11/16/2023
Jessica Garlewicz
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for DNA stability and repair and plays a role in maintaining normal hair growth.
Zinc is a crucial element for...
11/16/2023
The Dermatologist
alopecia areata
News
10/23/2023
Jessica Garlewicz
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate the link between alopecia areata and hearing problems.
Researchers aimed to investigate...
10/23/2023
The Dermatologist
Collagen and vitamin drop skin cell
News
10/29/2026
Coleen Stern, MA
The US Department of Health and Human Services has outlined an interim enforcement policy for compounding 6 peptide bulk drug substances while their inclusion on the section 503A bulks list is considered through rulemaking.
The US Department of Health and Human Services has outlined an interim enforcement policy for compounding 6 peptide bulk drug substances while their inclusion on the section 503A bulks list is considered through rulemaking.
The US Department of Health and...
10/29/2026
The Dermatologist
cream
News
10/13/2026
Coleen Stern, MA
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid...
10/13/2026
The Dermatologist
FDA Alerts
10/08/2026
Jessica Garlewicz
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food and Drug Administration approved remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, as the first treatment for adults with symptomatic dermographism inadequately controlled by H1...
On October 7, 2026, the US Food...
10/08/2026
The Dermatologist
GLP-1
News
10/07/2026
Jessica Garlewicz
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor...
10/07/2026
The Dermatologist
Smiling woman touching neck
News
10/01/2026
Coleen Stern, MA
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an...
10/01/2026
The Dermatologist
dkin
News
09/30/2026
Coleen Stern, MA
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an...
09/30/2026
The Dermatologist
FDA Alerts
09/28/2026
Riya Gandhi, MA
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication...
09/28/2026
The Dermatologist
Global travel
News
09/03/2026
Jessica Garlewicz
Investigators assessed trends in psoriasis cases, effects on quality of life, and associated economic costs.
Investigators assessed trends in psoriasis cases, effects on quality of life, and associated economic costs.
Investigators assessed trends in...
09/03/2026
The Dermatologist
FDA Alerts
08/31/2026
Coleen Stern, MA
For dermatologists and patients, this approval provides a new alternative targeting the JAK-mediated inflammation that damages the muscles and skin in dermatomyositis to control both cutaneous and systemic manifestations.
For dermatologists and patients, this approval provides a new alternative targeting the JAK-mediated inflammation that damages the muscles and skin in dermatomyositis to control both cutaneous and systemic manifestations.
For dermatologists and patients,...
08/31/2026
The Dermatologist
FDA Alerts
08/07/2026
Jessica Garlewicz
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug Administration (FDA) has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg) in combination with nivolumab for the treatment of adults with unresectable advanced cutaneous melanoma.
The US Food and Drug...
08/07/2026
The Dermatologist

Quizzes and Polls

Quiz
03/29/2019
Which finding is common among patients with alopecia areata affecting the nails?
Which finding is common among patients with alopecia areata affecting the nails?
Which finding is common among...
03/29/2019
The Dermatologist
Quiz
Quiz
11/16/2026
Riya Gandhi, MA
Challenge your clinical reasoning in managing prurigo nodularis through targeted therapies, treatment sequencing, and interpretation of variable therapeutic responses.
Challenge your clinical reasoning in managing prurigo nodularis through targeted therapies, treatment sequencing, and interpretation of variable therapeutic responses.
Challenge your clinical...
11/16/2026
The Dermatologist
Quiz
Quiz
11/09/2026
Riya Gandhi, MA
Test your understanding of the complex interactions among inflammatory cytokines, sensory neurons, and tissue remodeling in prurigo nodularis.
Test your understanding of the complex interactions among inflammatory cytokines, sensory neurons, and tissue remodeling in prurigo nodularis.
Test your understanding of the...
11/09/2026
The Dermatologist
Physician with child
Quiz
11/03/2026
Jessica Garlewicz
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged...
11/03/2026
The Dermatologist
magnifying glass in front of stacks of books
Quiz
11/02/2026
Riya Gandhi, MA
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical...
11/02/2026
The Dermatologist
Illustration-depicting-knowledge-or-education
Quiz
11/02/2026
Riya Gandhi, MA
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of...
11/02/2026
The Dermatologist
Clock for test
Quiz
11/02/2026
Riya Gandhi, MA
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding...
11/02/2026
The Dermatologist
Book with arrows
Quiz
10/25/2026
Riya Gandhi, MA
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of...
10/25/2026
The Dermatologist
AD
Quiz
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
HS
Quiz
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist